Home LiteratureArticle Details
PMID: 1854176 Published · ppublish English Journal Article

Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Antimicrobial agents and chemotherapy ·Vol. 35 ·No. 5 ·1991-05-00 ·Pages 948-54

Yeaman MR, Baca OG

Abstract

The Nine Mile, S Q217, and Priscilla isolates, representative of the three major genetic groups of Coxiella burnetii, are known to differ in their susceptibilities to antibiotics. Mechanisms potentially responsible for these differences were investigated. Accumulation of antibiotics by infected L929 cells and purified isolates was measured. In addition, C. burnetii plasmid-transformed Escherichia coli HB101 cells were used to study the possibility that different C. burnetii plasmids are responsible for disparate antibiotic susceptibilities of the isolates. L929 cells recently or persistently infected with the Priscilla isolate exhibited a significantly reduced accumulation of [3H]tetracycline as compared with that in L929 cells infected with either the Nine Mile or S Q217 isolates; accumulation of this drug was greater in cells recently infected each isolate. In contrast, L929 cells recently or persistently infected with the different isolates accumulated [3H]norfloxacin to an equivalent extent. [3H]tetracycline accumulation was approximately the same among the purified isolates. However, as measured by both scintillation and spectrofluorometry, norfloxacin accumulation was significantly diminished in the purified Priscilla isolate. pH had no apparent effect upon isolate permeabilities. The presence of C. burnetii QpH1 or QpRS plasmids did not alter the antibiotic susceptibility of E. coli. Collectively, these results indicate that differential susceptibilities to tetracyclines or fluoroquinolones in C. burnetii isolates may be the result of distinct mechanisms involving altered host-cell (tetracyclines) or isolate-specific (fluoroquinolones) permeabilities.

MeSH Terms
Animals Anti-Bacterial Agents/pharmacology Cells, Cultured Coxiella/drug effects,genetics,metabolism Culture Media Escherichia coli/genetics Fibroblasts/metabolism Hydrogen-Ion Concentration Mice Microbial Sensitivity Tests Norfloxacin/metabolism Plasmids Tetracycline/metabolism Transduction, Genetic
Chemicals
Anti-Bacterial Agents Culture Media Tetracycline Norfloxacin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Yeaman M R
Department of Biology, University of New Mexico, Albuquerque 87131.
Baca O G
References (28)
28 references, click to expand
  1. ACCUMULATION OF OXYTETRACYCLINE RELEVANT TO ITS BACTERICIDAL ACTION IN THE CELLS OF ESCHERICHIA COLI.
    Nature. 1963 Oct 12;200:192-3 PMID: 14073055
  2. Tetracycline inhibition of cell-free protein synthesis. II. Effect of the binding of tetracycline to the components of the system.
    J Bacteriol. 1966 Jul;92(1):197-203 PMID: 5328750
  3. Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.
    J Antimicrob Chemother. 1986 Dec;18(6):667-74 PMID: 3029010
  4. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.
    Antimicrob Agents Chemother. 1987 Jul;31(7):1079-84 PMID: 3662472
  5. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  6. Uptake of ciprofloxacin by human neutrophils.
    J Antimicrob Chemother. 1985 Jul;16(1):67-73 PMID: 2931414
  7. Uptake of ciprofloxacin by macrophages.
    J Clin Pathol. 1985 Apr;38(4):442-4 PMID: 3157704
  8. Routes of quinolone permeation in Escherichia coli.
    Antimicrob Agents Chemother. 1988 Apr;32(4):438-42 PMID: 3132091
  9. Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
    Antimicrob Agents Chemother. 1988 Aug;32(8):1187-91 PMID: 3056253
  10. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes.
    Antimicrob Agents Chemother. 1989 Jul;33(7):1052-7 PMID: 2782856
  11. Alterations in outer membrane permeability.
    Annu Rev Microbiol. 1984;38:237-64 PMID: 6093683
  12. Elimination of a virulence plasmid from Shigella sonnei and Escherichia coli by antibiotics.
    Ann Inst Pasteur Microbiol. 1986 Nov-Dec;137B(3):291-5 PMID: 3318870
  13. The mode of action of 4-quinolones and possible mechanisms of resistance.
    J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9 PMID: 3542946
  14. A proposed model to explain persistent infection of host cells with Coxiella burnetii.
    J Gen Microbiol. 1986 May;132(5):1415-22 PMID: 3772338
  15. Elimination of plasmids by new 4-quinolones.
    Antimicrob Agents Chemother. 1985 Nov;28(5):700-2 PMID: 3911881
  16. Correlation of plasmid type and disease caused by Coxiella burnetii.
    Infect Immun. 1985 Sep;49(3):775-9 PMID: 4030104
  17. Ciprofloxacin in a case of Q fever endocarditis.
    N Engl J Med. 1990 Aug 30;323(9):614 PMID: 2381451
  18. Chronic Q fever: diagnosis and follow-up.
    Ann N Y Acad Sci. 1990;590:51-60 PMID: 2378473
  19. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii.
    Ann N Y Acad Sci. 1990;590:297-305 PMID: 2378461
  20. Isolation and characterization of a plasmid from phase I Coxiella burnetii.
    Infect Immun. 1983 Aug;41(2):488-93 PMID: 6307871
  21. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii.
    Proc Natl Acad Sci U S A. 1981 May;78(5):3240-4 PMID: 6942430
  22. Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines.
    Infect Immun. 1981 Jul;33(1):258-66 PMID: 7263063
  23. Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components.
    Infect Immun. 1981 May;32(2):840-51 PMID: 7251150
  24. Two transport systems for tetracycline in sensitive Escherichia coli: critical role for an initial rapid uptake system insensitive to energy inhibitors.
    Antimicrob Agents Chemother. 1978 Aug;14(2):201-9 PMID: 358917
  25. Interaction of intraleukocytic bacteria and antibiotics.
    J Clin Invest. 1973 Jul;52(7):1673-9 PMID: 4718959
  26. Inhibition of mammalian protein synthesis by antibiotics.
    Pharmacol Rev. 1969 Sep;21(3):213-45 PMID: 4899142
  27. Method for counting Rickettsiae and Chlamydiae in purified suspensions.
    J Bacteriol. 1968 Jan;95(1):259-61 PMID: 4866101
  28. The inhibition of incorporation of leucine into protein of cell-free systems from rat liver and Escherichia coli by chlortetracycline.
    Biochem J. 1963 Jun;87:449-53 PMID: 13959276
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1991-05-00
Pages
948-54
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC245134
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com